Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Latest filing published 03 Jun 2026 for Amphastar Pharmaceuticals, Inc.. Read the official filing
Filing timeline
BuySaleGayle Deflin
Insider track record
Disclosed buys
0
Disclosed sells
3
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Gayle Deflin: trading record in brief
Gayle Deflin is a declared insider of Amphastar Pharmaceuticals, Inc. (board member), with filings sourced from SEC (Form 4). In total, 9 filings cover trades dated from 7 June 2021 to 1 June 2026.
On the market, this insider has only sold: 3 sales, €460k in total. Besides market trades, the filings include 6 share grants.
On 3 June 2026 came the latest disclosure, a share grant in Amphastar Pharmaceuticals, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Gayle Deflin
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations9 total
8,143 shares0Common StockSEC:0001866024-26-000003:0
5,122 shares0Common StockSEC:0001415889-25-015676:0
3,076 shares0Common StockSEC:0001415889-24-015656:0
4,163 shares@ US$55.4546.9% of flowCommon StockSEC:0001104659-23-118693:0
2,716 shares0Common StockSEC:0001104659-23-068974:0
4,519 shares@ US$44.011640.1% of flowCommon StockSEC:0001104659-23-062798:0
1,500 shares@ US$43.151812.9% of flowCommon StockSEC:0001104659-23-061819:0
4,163 shares0Common StockSEC:0001104659-22-071075:0
6,019 shares0Common StockSEC:0001104659-21-078408:0
9 of 9 declarations
